Based in India, Ankit is a financial content writer and stock market
analyst. He has worked for almost a decade on several financial
projects related to the stock market news, fundamental research and
technical analysis for several websites. He obtained his Masters
Degree In finance (MS – finance) from ICFAI. Currently, he serves as
a financial consultant and technical analyst at Tradersinsights.com.
We’ve shortlisted four major biotech stocks with upcoming news in April related to FDA decisions. Where will the news take GW Pharmaceuticals (NASDAQ:GWPH), FibroGen (NASDAQ:FGEN), Heron Therapeutics (NASDAQ:HRTX), and Assembly Biosciences (NASDAQ:ASMB)?
AVEO stock continued to gain momentum in Tuesday’s session and was recently trading up by 13.50% to $1.26 USD, extending its winning streak for the third straight session. Shares of AVEO Pharmaceuticals (NASDAQ:AVEO), a biopharmaceutical …
This month, shares of Sorrento Therapeutics (NASDAQ:SRNE) have had the best monthly gain in the last 12-month period. Shares of the clinical-stage biotech company have jumped as much as 134% from $2.03 to $4.75 during …